Transdermal Drug Delivery System Market Share, Size, and Trends by 2031
Transdermal Drug Delivery System Market: Strategic Insights
Transdermal Drug Delivery System Market
-
CAGR (2022 - 2030)4.3% -
Market Size 2022
US$ 37,230.28 Million -
Market Size 2030
US$ 51,949.74 Million
Market Dynamics
GROWTH DRIVERS
- Introduction of advanced transdermal drug delivery systems to boost their global uptake
FUTURE TRENDS
- Adoption of 3D printing technology and smart patches is likely to offer opportunities to the transdermal drug delivery systems market
OPPORTUNITIES
- Advantages associated with a noninvasive drug delivery facilitated by transdermal drug delivery systems to drive the market growth
Key Players
- Novartis AG
- GSK Plc
- Viatris Inc
- Boehringer Ingelheim International GmbH
- Lavipharm SA
- Hisamitsu Pharmaceutical Co Inc
- Johnson Johnson
- Luye Pharma Group Ltd
- Purdue Pharma LP
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Type - Transdermal Patches
- Transdermal Gel
- Transdermal Sprays
Application - Cardiovascular Diseases
- Central Nervous System Disorders
- Pain Management
- Hormonal Applications
- Other Applications
Distribution Channel - Hospitals Pharmacies
- Retail Phamacies
- Online Pharmacies
Get Free Sample For